These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 5763710)

  • 1. Intermittent interferon inefficient?
    Mitler HE
    N Engl J Med; 1969 Feb; 280(9):508. PubMed ID: 5763710
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interferon--clinical application].
    Zamorska I; Kozłowski M
    Wiad Lek; 1990 Jun; 43(11):548-51. PubMed ID: 1699362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of interferons in clinical radiotherapy.
    Mossman KL; Hill LT; Dritschilo A
    J Natl Med Assoc; 1982 Nov; 74(11):1083-7. PubMed ID: 6184481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interferon in search of a disease].
    van der Noordaa J
    Ned Tijdschr Geneeskd; 1980 Sep; 124(39):1650. PubMed ID: 6157999
    [No Abstract]   [Full Text] [Related]  

  • 5. What not to say about interferon.
    Nature; 1980 Jun; 285(5767):603-4. PubMed ID: 6156416
    [No Abstract]   [Full Text] [Related]  

  • 6. Interferons and their antitumor properties.
    Platanias LC
    J Interferon Cytokine Res; 2013 Apr; 33(4):143-4. PubMed ID: 23570379
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interferon 1976. II. The significance of interferon in medicine (author's transl)].
    Borecký L
    Bratisl Lek Listy; 1976 Dec; 66(6):645-52. PubMed ID: 1022321
    [No Abstract]   [Full Text] [Related]  

  • 8. Less empirical interferon trials in cancer.
    Schultz RM
    Lancet; 1980 Dec 20-27; 2(8208-8209):1362. PubMed ID: 6161288
    [No Abstract]   [Full Text] [Related]  

  • 9. The natural killer cell-interferon system in human carcinoma--its relation to interferon cancer treatment trials.
    Ching NP; Ching CY; Jim EL; Loh KK; Oishi N; Yim DW
    Hawaii Med J; 1984 Oct; 43(10):368-72. PubMed ID: 6210268
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs and dosages: interferon.
    Occup Health Nurs; 1980 May; 28(5):47. PubMed ID: 6154910
    [No Abstract]   [Full Text] [Related]  

  • 11. Some comments on interferon.
    Gams RA
    Ala J Med Sci; 1980 Apr; 17(2):120-1. PubMed ID: 6158273
    [No Abstract]   [Full Text] [Related]  

  • 12. [Interferon].
    Schürmann W
    Krankenpfl J; 1981 Aug; 19(8):16-8. PubMed ID: 6169876
    [No Abstract]   [Full Text] [Related]  

  • 13. [Interferon--the prospects and problems of its use in therapeutic and oncological practice].
    Poverennyĭ AM
    Med Radiol (Mosk); 1983 Jun; 28(6):67-71. PubMed ID: 6191171
    [No Abstract]   [Full Text] [Related]  

  • 14. Interferons and cancer: how the promise is being kept.
    Borden EC
    Interferon; 1983; 5():43-83. PubMed ID: 6202643
    [No Abstract]   [Full Text] [Related]  

  • 15. Interferon in Michigan.
    Rich J
    Mich Med; 1981 Aug; 80(23):402. PubMed ID: 6167843
    [No Abstract]   [Full Text] [Related]  

  • 16. Interferon: an early evaluation.
    McCredie KB; Moore MS
    J Okla State Med Assoc; 1980 Sep; 73(9):325-8. PubMed ID: 6160226
    [No Abstract]   [Full Text] [Related]  

  • 17. Interferon: IFs and buts of cancer treatment.
    Iveson-Iveson J
    Nurs Mirror; 1980 Jul; 151(5):34-6. PubMed ID: 6157150
    [No Abstract]   [Full Text] [Related]  

  • 18. At year's end, what's new with interferon?
    Check WA
    JAMA; 1979 Dec; 242(26):2829-30. PubMed ID: 513240
    [No Abstract]   [Full Text] [Related]  

  • 19. [Interferon in antitumoral chemotherapy].
    Soria M
    Recenti Prog Med; 1981 May; 70(5):494-523. PubMed ID: 6171850
    [No Abstract]   [Full Text] [Related]  

  • 20. Interferon preparations and contaminating endotoxin.
    Fumarola D; Miragliotta G
    Infection; 1981; 9(5):255. PubMed ID: 6170586
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.